Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

79°
- Benton, AR (72018)
  Today
  
  Cloudy with occasional rain showers. High near 85F. Winds NW at 5 to 10 mph. Chance of rain 50%..
  
  Tonight
  
  Areas of patchy fog early. Partly cloudy. Low 69F. Winds light and variable.
  
  Updated: May 29, 2026 @ 12:25 pm
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2026
Community Calendar

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Praxis Precision Medicines, Inc. - Common Stock (NQ:PRAX)

339.22 -13.41 (-3.80%)

Streaming Delayed Price Updated: 1:27 PM EDT, May 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Praxis Precision Medicines, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 26, 2024

Via Benzinga

Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patients

March 26, 2024

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines to Host PRAX-628 Program Update

March 25, 2024

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

PRAX Stock Earnings: Praxis Precision Medicine Beats EPS, Beats Revenue for Q4 2023 ↗

March 05, 2024

PRAX stock results show that Praxis Precision Medicine beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Recap: Praxis Precision Medicine Q4 Earnings ↗

March 05, 2024

Via Benzinga

Where Praxis Precision Medicine Stands With Analysts ↗

October 03, 2023

Via Benzinga

What 5 Analyst Ratings Have To Say About Praxis Precision Medicine ↗

August 10, 2023

Via Benzinga

Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

March 05, 2024

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines to Participate in TD Cowen’s 44th Annual Health Care Conference

March 01, 2024

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 02, 2024

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month ↗

January 25, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is "too risky."

Via Benzinga

Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week ↗

January 13, 2024

Shanghai Argo Biopharma entered 2 agreements with Novartis, out-licensing four next-gen RNAi therapeutics for $185 million upfront and a total value of $4.2 billion. Additionally, Ambrx Biopharma will...

Via Talk Markets

Praxis Precision Medicines, Inc. Announces Pricing of $150.0 Million Public Offering

January 11, 2024

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines, Inc. Announces Proposed Public Offering

January 10, 2024

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 08, 2024

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...

Via Benzinga

Praxis Precision Medicines Provides Update on Advancing Clinical Stage Portfolio

January 08, 2024

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines Announces Licensing and Collaboration Agreement with Tenacia Biotechnology for Ulixacaltamide in Greater China

January 05, 2024

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines to Showcase Largest Pipeline of Precision Epilepsy Programs and Breadth of Commitment to Epilepsy Treatments at Upcoming Meetings

November 28, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines to Present at the Piper Sandler 35th Annual Healthcare Conference

November 21, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental Epilepsies

November 16, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial Results

November 07, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines to Present at Truist Securities BioPharma Symposium

November 02, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines Provides Portfolio Update at 2023 R&D Day

October 02, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines To Host Hybrid R&D Day on Monday, October 2, 2023

September 27, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023 ↗

September 19, 2023

Via Benzinga

Praxis Precision Medicines to Present at H.C. Wainwright 25th Annual Global Investment Conference

September 07, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines to Present Data from Epilepsy Portfolio at the 35th International Epilepsy Congress

August 31, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines to Present Analyses of Patient-Focused, Clinically Meaningful Endpoints from Essential1 Study of Ulixacaltamide in Essential Tremor at the 2023 MDS International Congress

August 28, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Top 5 Health Care Stocks That May Fall Off A Cliff ↗

August 23, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results

August 09, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

Praxis Precision Medicines, Inc. - Common Stock (NQ:PRAX)

All News about Praxis Precision Medicines, Inc. - Common Stock

Sections

Services

Follow Us